What did @harleymeds.com actually say?
The creator, presenting themselves as a clinic operator, told viewers that their standard starting dose for first-time TRT patients is "between 120 and 150 milligrams." They described a three-month follow-up blood panel to assess levels, with possible dose adjustments after that. The video ends with a direct-to-consumer pitch: comment "TRT" to get started online, "fast and easy."
That last part matters. This is not a neutral educational video. It is a recruitment ad with clinical-sounding framing. The dose range mentioned, the timeline described, and the casual online signup pitch all deserve scrutiny on their own terms.
Does the science back this up?
The 120-150mg weekly range is broadly within clinical use, but calling it a universal starting point oversimplifies what actual guidelines say. The Endocrine Society's 2018 clinical practice guidelines recommend individualizing testosterone dosing based on baseline levels, symptoms, age, and formulation. There is no single correct starting dose.
Most clinical protocols for testosterone cypionate or enanthate start between 75mg and 200mg weekly, depending on the patient. The 100mg weekly starting dose is common in primary care and urology. The 120-150mg range @harleymeds.com cites skews toward the higher end of conservative starting doses. A 2020 review by Morgentaler et al. in the Journal of Sexual Medicine emphasized that starting lower and titrating upward reduces the risk of erythrocytosis and supraphysiologic peaks, particularly in older men or those with cardiovascular history. The creator does not acknowledge any of that nuance.
The three-month blood work timeline is consistent with Endocrine Society and American Urological Association recommendations, so that part checks out.
What did they get wrong (or right)?
Credit where it is due: the mention of follow-up blood work at three months is clinically appropriate. That is not nothing. Many online TRT mills skip monitoring entirely or make it inconvenient enough that patients just stop bothering. A structured check-in at three months aligns with published guidelines.
What they got wrong is the framing of 120-150mg as a standard starting point without any context about who that applies to. A 28-year-old with total testosterone of 280 ng/dL and a 61-year-old with cardiovascular risk factors are not the same patient. Blanket dosing recommendations, even rough ones, posted to a platform with 86,000 views on a video, can lead people to self-advocate for doses that are too high for their situation.
The "fast and easy" pitch at the end is the part that should give anyone pause. Legitimate TRT initiation requires lab work, symptom evaluation, and a clinical conversation. Packaging that as a social media comment funnel is not good medicine, whatever the dose range cited.
What should you actually know?
TRT dosing is not one-size-fits-all. The Endocrine Society defines hypogonadism as a total testosterone consistently below 300 ng/dL with accompanying symptoms. The goal of treatment is to bring levels into the normal physiologic range, roughly 400-700 ng/dL for most men, not to maximize numbers.
Starting doses in clinical practice typically range from 75mg to 150mg weekly for injectable testosterone cypionate or enanthate, with adjustments based on trough levels drawn before the next injection. Bhasin et al. (2010, New England Journal of Medicine) demonstrated dose-dependent effects on muscle mass and adverse events, reinforcing the case for starting conservatively and titrating carefully.
Key risks that go unmentioned in this video include erythrocytosis (elevated red blood cell mass), suppression of sperm production, and changes in hematocrit that require monitoring. These are not rare edge cases. They are expected physiologic responses that every provider starting someone on TRT should discuss before prescribing. Anyone considering TRT, whether through a telehealth platform or an in-person clinic, should expect a full metabolic and hormonal panel before a prescription is written, not after they comment on a TikTok video.